Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Molecular and Cellular Biology, Genetics

Abstract LB-162: BRCA2, and not BRCA1, dependent crosstalk between replication stress suppression and nucleotide excision repair - Clinical implications

Shailja Pathania, Rachel Reed, Haohui Duan, Aedin Culhane and Judy Garber
Shailja Pathania
Dana Farber Cancer Institute and Harvard Medical School, Boston, MA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachel Reed
Dana Farber Cancer Institute and Harvard Medical School, Boston, MA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haohui Duan
Dana Farber Cancer Institute and Harvard Medical School, Boston, MA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aedin Culhane
Dana Farber Cancer Institute and Harvard Medical School, Boston, MA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Judy Garber
Dana Farber Cancer Institute and Harvard Medical School, Boston, MA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1538-7445.AM2016-LB-162 Published July 2016
  • Article
  • Info & Metrics
Loading
Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA

Abstract

BRCA2, a breast and ovarian tumor suppressor, is required for replication stress suppression through its role in repair of stalled replication forks. Here we report that inefficient resolution of stalled replication forks in absence of BRCA2 results in persistent accumulation of mostly un-phosphorylated RPA32 (at S33, T21 and S4/S8) at stalled replication forks. Furthermore, this ‘persistent’ accumulation of RPA32 coated ssDNA not only results in fork collapse, as marked by increased accumulation of both 53BP1 and Mre11 at the site of stalling, but also leads to suppression of nucleotide excision repair (NER), especially in S phase population. No such persistent RPA32 coated ssDNA is observed in BRCA1 depleted cells, suggesting that this intermediate is exclusive to BRCA2 deficiency. Furthermore, generation of this intermediate was not dependent on Mre11 implying that persistent accumulation of RPA32 coated ssDNA was not a result of excessive DNA processing by Mre11 exonuclease in absence of BRCA2. This is the first report of differences between BRCA1 and BRCA2 role at stalled replication forks. In this report, we also show that BRCA2 heterozygous primary mammary epithelial cells, and not BRCA1 heterozygous cells, are haploinsufficient for nucleotide excision repair. This would imply higher predisposition to skin lesions, including melanoma in BRCA2 mutation carriers. Risk for melanoma is indeed higher in BRCA2 mutation carriers compared to BRCA1 mutation carriers. We further confirmed that there exists a difference in mutational signature in whole genome sequences derived from BRCA1 and BRCA2 tumors, in line with the kind of differences expected if there is an increased NER defect in BRCA2 mutated cells when compared to BRCA1 mutated cells.

Our findings provide first such DNA repair mechanism based evidence that could potentially explain the differences in BRCA1 and BRCA2 mutation driven risk for melanoma. This mechanistic difference between BRCA1 and BRCA2 response at stalled replication forks, and subsequently a crosstalk with nucleotide excision repair, might also contribute towards other clinical differences observed in BRCA1 and BRCA2 mutation driven breast cancer.

Citation Format: Shailja Pathania, Rachel Reed, Haohui Duan, Aedin Culhane, Judy Garber. BRCA2, and not BRCA1, dependent crosstalk between replication stress suppression and nucleotide excision repair - Clinical implications. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr LB-162.

  • ©2016 American Association for Cancer Research.
Previous
Back to top
Cancer Research: 76 (14 Supplement)
July 2016
Volume 76, Issue 14 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract LB-162: BRCA2, and not BRCA1, dependent crosstalk between replication stress suppression and nucleotide excision repair - Clinical implications
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract LB-162: BRCA2, and not BRCA1, dependent crosstalk between replication stress suppression and nucleotide excision repair - Clinical implications
Shailja Pathania, Rachel Reed, Haohui Duan, Aedin Culhane and Judy Garber
Cancer Res July 15 2016 (76) (14 Supplement) LB-162; DOI: 10.1158/1538-7445.AM2016-LB-162

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract LB-162: BRCA2, and not BRCA1, dependent crosstalk between replication stress suppression and nucleotide excision repair - Clinical implications
Shailja Pathania, Rachel Reed, Haohui Duan, Aedin Culhane and Judy Garber
Cancer Res July 15 2016 (76) (14 Supplement) LB-162; DOI: 10.1158/1538-7445.AM2016-LB-162
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Molecular and Cellular Biology, Genetics

  • Abstract LB-271: SplashRNA, a sequential classification algorithm for ultra-potent RNAi
  • Abstract LB-270: Hexokinase II (HK2) regulates stemness of ovarian cancer cells
  • Abstract LB-277: Four noval activating and resistance mutations of EGFR drug response targets were discovered in northern Chinese patients
Show more 3

Poster Presentations - Late-Breaking Abstracts

  • Abstract LB-275: Precise enumeration of cell-free DNA from patient-derived cell lines
  • Abstract LB-270: Hexokinase II (HK2) regulates stemness of ovarian cancer cells
  • Abstract LB-268: Rate of temporal citrate efflux from malignant mitochondria predicts clinical aggressiveness in breast tumors
Show more 3

Poster Presentations - Late-Breaking Research: Molecular and Cellular Biology 2

  • Abstract LB-088: Role of histone demethylase JMJD1A in the generation of AR-V7
  • Abstract LB-083: Core transcriptional regulatory circuitries in neuroblastoma
  • Abstract LB-097: DNA methylation at enhancers distinguishes distinct breast cancer lineages
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement